Radiolabeled somatostatin (SST) analogs, used to visualize and treat SST receptor (SSTR)-expressing neuroendocrine tumors, also accumulate in the spleen. There is a high interpatient variation and no significant radiation-induced splenic toxicity; however, an absorbed dose-related reduction in spleen size was detected. However, the exact localization of radioactivity and the role of SST receptors in splenic retention are unknown. Therefore, we performed ex vivo micro-SPECT of the isolated spleen from a patient with a pancreatic neoplasm after 1 GBq (27 mCi) Lu-DOTATATE administration, followed by autoradiography and immunohistochemistry. Ex vivo autoradiography demonstrated convincingly that most radioactivity accumulated in red pulp.

doi.org/10.1097/RLU.0000000000001026, hdl.handle.net/1765/96936
Clinical Nuclear Medicine
Department of Nuclear Medicine

Melis, M., Kaemmerer, D., de Swart, J., Kulkarni, H. R., Lupp, A., Sänger, J., … Baüm, R. (2016). Localization of Radiolabeled Somatostatin Analogs in the Spleen. Clinical Nuclear Medicine, 41(2), e111–e114. doi:10.1097/RLU.0000000000001026